Upgrade to SI Premium - Free Trial

ANI Pharma (ANIP)

72.77 +0.53 (0.73%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/11/26)

Latest Headlines

ANI Pharmaceuticals launches generic version of Cymbalta October 19, 2026 6:57 AM - StreetInsider ANI Pharmaceuticals Announces the Launch of Duloxetine Delayed-Release Capsules October 19, 2026 6:55 AM - StreetInsider Form 4 ANI PHARMACEUTICALS INC For: Oct 15 Filed by: Lalwani Nikhil October 16, 2026 6:50 PM - SEC Filing Form 144 ANI PHARMACEUTICALS INC Filed by: Lalwani Nikhil October 15, 2026 4:26 PM - SEC Filing Form 4 ANI PHARMACEUTICALS INC For: Oct 13 Filed by: Cook Meredith October 13, 2026 8:48 PM - SEC Filing ANI Pharmaceuticals reports positive phase 4 uveitis trial data October 12, 2026 6:55 AM - StreetInsider ANI Pharmaceuticals Announces Positive Phase 4 Open-Label, Single-Arm SYNCHRONICITY Clinical Trial Results Presented as Late Breaking Oral Presentation at the American Academy of Ophthalmology 2026 An October 12, 2026 6:55 AM - StreetInsider Form 4 ANI PHARMACEUTICALS INC For: Sep 29 Filed by: CAREY STEPHEN P. September 30, 2026 4:52 PM - SEC Filing ANI Pharmaceuticals to present eye implant data at AAO 2026 meeting September 30, 2026 6:55 AM - StreetInsider ANI Pharmaceuticals Announces New Fluocinolone Acetonide Intravitreal Implant Data to be Presented at the American Academy of Ophthalmology 2026 Annual Meeting September 30, 2026 6:55 AM - StreetInsider ANI Pharmaceuticals gets FDA approval for generic everolimus suspension September 23, 2026 6:55 AM - StreetInsider ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension September 23, 2026 6:55 AM - StreetInsider Oppenheimer Starts ANI Pharmaceuticals (ANIP) at Perform September 23, 2026 6:06 AM - StreetInsider Form 4 ANI PHARMACEUTICALS INC For: Aug 25 Filed by: Lalwani Nikhil September 18, 2026 12:39 PM - SEC Filing Form 4 ANI PHARMACEUTICALS INC For: Sep 15 Filed by: Lalwani Nikhil September 16, 2026 4:21 PM - SEC Filing Form 144 ANI PHARMACEUTICALS INC Filed by: Lalwani Nikhil September 15, 2026 4:24 PM - SEC Filing Form 4 ANI PHARMACEUTICALS INC For: Sep 11 Filed by: Thoma Jeanne September 14, 2026 8:57 PM - SEC Filing Form 4 ANI PHARMACEUTICALS INC For: Sep 14 Filed by: Cook Meredith September 14, 2026 8:57 PM - SEC Filing Form 144 ANI PHARMACEUTICALS INC Filed by: Thoma Jeanne September 11, 2026 4:33 PM - SEC Filing Leerink Starts ANI Pharmaceuticals (ANIP) at Outperform September 9, 2026 6:49 AM - StreetInsider ANI Pharmaceuticals to Present at September Investor Conferences September 3, 2026 6:55 AM - StreetInsider Form 4 ANI PHARMACEUTICALS INC For: Aug 19 Filed by: Gosebruch Henry O August 27, 2026 4:22 PM - SEC Filing Form 3 ANI PHARMACEUTICALS INC For: Aug 19 Filed by: Gosebruch Henry O August 27, 2026 4:21 PM - SEC Filing Form 4 ANI PHARMACEUTICALS INC For: Aug 25 Filed by: Lalwani Nikhil August 26, 2026 6:15 PM - SEC Filing Form 144 ANI PHARMACEUTICALS INC Filed by: Lalwani Nikhil August 25, 2026 4:42 PM - SEC Filing Form 8-K ANI PHARMACEUTICALS INC For: Aug 19 August 24, 2026 7:01 AM - SEC Filing ANI Pharmaceuticals adds Henry Gosebruch to its board August 24, 2026 6:55 AM - StreetInsider ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors  August 24, 2026 6:55 AM - StreetInsider Form 4 ANI PHARMACEUTICALS INC For: Aug 13 Filed by: Cook Meredith August 13, 2026 4:34 PM - SEC Filing Form 4 ANI PHARMACEUTICALS INC For: Aug 10 Filed by: Gutwerg Ori August 11, 2026 8:58 PM - SEC Filing ANI Pharmaceuticals (ANIP) PT Lowered to $119 at Guggenheim August 10, 2026 7:28 AM - StreetInsider ANI Pharmaceuticals (ANIP) PT Lowered to $90 at Canaccord August 10, 2026 7:00 AM - StreetInsider ANI Pharma (ANIP) Tops Q2 EPS by 18c ; Offers Guidance August 7, 2026 7:34 AM - StreetInsider Form 10-Q ANI PHARMACEUTICALS INC For: Jun 30 August 7, 2026 7:02 AM - SEC Filing Form 8-K ANI PHARMACEUTICALS INC For: Aug 07 August 7, 2026 7:00 AM - SEC Filing ANI Pharmaceuticals Reports Record Second Quarter 2026 Financial Results August 7, 2026 6:50 AM - StreetInsider Form 4 ANI PHARMACEUTICALS INC For: Jul 29 Filed by: CAREY STEPHEN P. July 30, 2026 4:03 PM - SEC Filing Form 144 ANI PHARMACEUTICALS INC Filed by: CAREY STEPHEN P. July 29, 2026 4:22 PM - SEC Filing Form SCHEDULE 13G/A ANI PHARMACEUTICALS INC Filed by: BlackRock, Inc. July 27, 2026 4:26 PM - SEC Filing ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET July 24, 2026 6:50 AM - StreetInsider Full Article List